Tests in 1,225 patients with the most deadly form of skin cancer reveal for the first time a genetic trait among most of ...

Reducing the length of immunotherapy treatment for an advanced skin cancer did not significantly diminish disease control ...

Adding immunotherapy to chemotherapy after surgery for stage 3 colon cancer may help decrease recurrence and death rate by 50 ...

Head and neck cancer patients went disease-free for five years, compared to half that time for people undergoing standard ...

Multiple myeloma is considered incurable, but a third of patients in a Johnson & Johnson clinical trial have lived without ...

Tests in 1,225 patients with the most deadly form of skin cancer reveal for the first time a genetic trait among most of ...

Drugs that boost the body's immune system to fight disease are showing promise in treating a variety of cancers in earlier ...

AN immune boosting drug can stave off throat cancer for years longer than current treatments, a trial found. Recovering head ...

Study examines treatment options for those with operable non-small cell lung cancer, the leading cause of cancer deaths ...

Bristol Myers Squibb has agreed to pay up to $11.1 billion to partner with Germany's BioNTech and develop the latter's ...

From antibody-drug conjugates to PARP inhibitors, innovative treatments are offering new hope for patients with ...

Pharmaceutical companies are making billions on treatments that can sometimes overpromise and underdeliver for terminal cases ...